Stroke: secondary prevention

Overview

Prevention in this context is the long-term management of people with previous stroke or transient ischaemic attack (TIA), and of people at high risk of stroke for other reasons such as atrial fibrillation. Stroke: Stroke is characterised by rapidly developing clinical symptoms and signs of focal, and at times global, loss of cerebral function lasting more than 24 hours or leading to death, with no apparent cause other than that of vascular origin. Ischaemic stroke is stroke caused by vascular insufficiency (such as cerebrovascular thromboembolism) rather than by haemorrhage. TIA: This is similar to a mild ischaemic stroke, except that symptoms last for less than 24 hours.[1] For management of stroke in the acute phase, see review on stroke management.

Latest citations

Totaled health risks in vascular events score predicts clinical outcome and symptomatic intracranial hemorrhage in chinese patients after thrombolysis. ( 22 May 2015 )

Efficacy of antiplatelet therapy in secondary prevention following lacunar stroke: pooled analysis of randomized trials. ( 05 May 2015 )